drugset / Trial / NCT06429137
A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated
RandomizedParallel-groupSingle-blindTreatment
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3731579 in healthy male subjects.
Timeline
- Start
- 2024-07-08
- Primary completion
- 2025-05-19
- Completion
- 2025-05-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 3731579 | Unknown | — | — |
Indications
No indication recorded.